Bcl-xL degrader（Zentalis）

N/A

Report date: 2023/03/02 09:40:36
NME

Base Information

Drug NameBcl-xL degrader（Zentalis）
Drug Alias NameN/A
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionApoptosis regulator Bcl-X degraders
TargetsApoptosis regulator Bcl-X
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZentalis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesZentalis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A